Sinisalo, Marjatta <br/><br/>
Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.  [electronic resource] 

 -  Leukemia & lymphoma  Apr 2011 
 - 724-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2010.551794  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--complications<br/>Male<br/>Middle Aged<br/>Platelet Count<br/>Receptors, Fc--therapeutic use<br/>Receptors, Thrombopoietin--agonists<br/>Recombinant Fusion Proteins--therapeutic use<br/>Thrombocytopenia--complications<br/>Thrombopoietin--therapeutic use<br/>Treatment Outcome